ESGO 2020 Hybrid Conference: A decade of advances in gynaecological cancer care
When it comes to meeting the right people in the right place, the 4th ESGO State of the Art Conference of the European Society of Gynaecological Oncology is a special event you don't want to miss in 2020...
ESGO 2020 brings together attendees from around the world for a unique 3-days gathering where the attendees can not only network with peers but also experience highly interactive format of the sessions and discuss the latest developements with key experts in the field of gynaecological oncology.
ESGO also follows all current regulations, recommendations and updates connected to Covid-19 pandemic and we can promise to all our participants that all safety measures will be strictly followed and maximum safety of all our attendees is our top priority.
The conference topics are of great interest to gynaecological surgeons, medical and radiation oncologists, pathologists, and general gynaecologists. This meeting provides an excellent opportunity to highlight to physicians, medical societies and governments the importance of improving research and treatment of gynaecological cancers, to improve management of gynaecological malignancies and to identify innovative therapies which remain a social responsibility for our society.
At the same time ESGO does realize that there may be travelling restrictions that can prevent some participants from attending the conference. That is why we have decided to have hybrid format so that no participants miss the experience. More details regarding the hybrid format will be published soon.
You can check the programme in your time zone here.
ESGO 2020 Highlights
+ Exclusive focus on the evidence base guidelines and standard operational procedures to manage gynecological cancers.
+ Comprehensive state-of-the art summaries on the advances in the management of Cervical, Endometrial, Ovarian and Vulvar cancers.
+ Up-to-date scientific reviews on the clinical trial landscape in collaboration with the European Network of Gynaecological Oncological Trial Groups (ENGOT)
+ New Format: Interactive Debates with key opinion leaders
+ Hybrid format for participants that cannot attend due to travel restriction in their country
The sessions will open with a case presentation followed by a keynote lecture and a debate with a panel of world experts to discuss the therapeutic approaches and recent advances.